Active Ingredient: HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Proprietary Name: OTICAIR
Dosage Form; Route of Administration: SUSPENSION/DROPS; OTIC
Strength: 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AT
Application Number: A064065
Product Number: 001
Approval Date: Aug 28, 1996
Applicant Holder Full Name: BAUSCH AND LOMB PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information